1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Nick Beije: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer ADT plus only 12 months of ARPI, ADT plus continued ARPI - Prostate Cancer | Phase 3 | Recruiting | Nick Beije | 400 | 2024-02-20 | 2025-12-03 |
Androgen Antagonists (1) · Single Person (1)
Netherlands (1)